{"id":183532,"date":"2026-08-04T13:51:27","date_gmt":"2026-08-04T08:21:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=183532"},"modified":"2026-08-04T13:51:27","modified_gmt":"2026-08-04T08:21:27","slug":"ambalal-sarabhai-enterprises-ltd-share-price-rise-2026-08-04","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ambalal-sarabhai-enterprises-ltd-share-price-rise-2026-08-04\/","title":{"rendered":"Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Share Price Rises Over 10% Today"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/ambalalsa\/ambalal-sarabhai-enterprises-ltd-share-price-today\">Ambalal Sarabhai Enterprises Ltd.<\/a> Share Price rises 10.31% today, reaching Rs 41.1 with a market cap of Rs 267.22 Cr.<\/p>\n<p style=\"margin-top:0!important;\">Ambalal Sarabhai Enterprises Ltd. Share Price has experienced a significant rise today, increasing by 10.31% to reach Rs 41.1. This notable price movement positions the company within the Micro Cap category, with a market capitalisation of Rs 267.22 crore. The stock opened at Rs 36.99 and reached a high of Rs 42, reflecting strong investor interest and trading activity. <\/p>\n<p>The rise in Ambalal Sarabhai Enterprises Ltd.&#8217;s share price today is a significant event in the context of the company&#8217;s market position and industry dynamics. As a Micro Cap company, the stock&#8217;s movement is closely watched by investors seeking opportunities in the Pharmaceuticals &#038; Drugs industry. The data confirms the price event but does not establish a company-specific catalyst, leaving room for further analysis and interpretation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Ambalal_Sarabhai_Enterprises_Ltd_AMBALALSA_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 41.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 37.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 3.84 (+10.31%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 36.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 42<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 36.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,20,568<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,20,568<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6,62,776<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7,83,344<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.5 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 267.22 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/table>\n<p>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) traded at Rs 41.1. versus the previous close of Rs 37.26, a rise of 10.31%. The stock opened at Rs 36.99, reached Rs 42, touched Rs 36.99. Reported volume was 1,20,568.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Ambalal_Sarabhai_Enterprises_Ltd_AMBALALSA_Fundamental_Analysis\"><\/span><strong>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 267.22 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.32<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Ambalal Sarabhai Enterprises Ltd. was valued at a P\/E ratio of 16.04x, a P\/B ratio of 1.8x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 48.74% and ROCE of 45.53%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 2.32, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<p>Ambalal Sarabhai Enterprises Ltd. is valued at a market capitalisation of Rs 267.22 crore, with a price-to-earnings (P\/E) ratio of 16.04 and a price-to-book (P\/B) ratio of 1.8. The company&#8217;s return on equity (ROE) stands at an impressive 48.74%, while the return on capital employed (ROCE) is 45.53%, indicating strong profitability and efficient capital utilisation.<\/p>\n<p>The company&#8217;s earnings per share (EPS) is Rs 2.32, reflecting the earnings attributable to each share. Despite a dividend yield of 0, the company&#8217;s strong ROE and ROCE highlight its ability to generate returns for shareholders. The fundamental analysis suggests that Ambalal Sarabhai Enterprises Ltd. is well-positioned within its industry, with valuation metrics that compare favourably to industry benchmarks.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">69.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.41x to 3,364.06x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.53%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 267.22 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 146.46 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a P\/E ratio of 16.04x, which is below the benchmark median of 25.88x, a difference of -38.02%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a ROE of 48.74%, which is above the benchmark median of 10.7%, a difference of +355.51%. Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a ROCE of 45.53%, which is above the benchmark median of 12.98%, a difference of +250.77%.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>Ambalal Sarabhai Enterprises Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals &#038; Drugs industry. The company&#8217;s P\/E ratio of 16.04 is below the industry median of 25.88, suggesting a relatively attractive valuation compared to its peers. The P\/B ratio of 1.8 is slightly above the industry median of 1.77, indicating a fair valuation in terms of book value.<\/p>\n<p>The company&#8217;s ROE of 48.74% and ROCE of 45.53% are significantly higher than the industry medians of 10.7% and 12.98%, respectively, highlighting its superior profitability and capital efficiency. With a market capitalisation of Rs 267.22 crore, Ambalal Sarabhai Enterprises Ltd. is positioned below the industry median, offering potential growth opportunities within the sector.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,931.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,731.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,683.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,580.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,474.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<\/table>\n<p>Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a P\/E ratio of 16.04x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.74% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 45.53% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a market capitalisation of Rs 267.22 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<p>In comparison to its peers, Ambalal Sarabhai Enterprises Ltd. demonstrates strong financial metrics. The company&#8217;s P\/E ratio of 16.04 is lower than Kwality Pharmaceuticals Ltd.&#8217;s 39.39 and Beta Drugs Ltd.&#8217;s 62.88, indicating a more attractive valuation. The ROE of 48.74% surpasses that of Hikal Ltd. at 15.22% and Solara Active Pharma Sciences Ltd. at 17.23%, showcasing its superior profitability.<\/p>\n<p>Ambalal Sarabhai Enterprises Ltd.&#8217;s ROCE of 45.53% is higher than the industry average, further emphasising its efficient capital utilisation. The company&#8217;s market capitalisation of Rs 267.22 crore is smaller compared to its larger peers, such as Dishman Carbogen Amcis Ltd. and Hikal Ltd., indicating potential for growth and expansion within the industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Ambalal_Sarabhai_Enterprises_Ltd\"><\/span><strong>Why Investors Are Watching Ambalal Sarabhai Enterprises Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are closely monitoring Ambalal Sarabhai Enterprises Ltd. due to its impressive price rise and strong financial performance. The company&#8217;s technical indicators suggest positive momentum, while its fundamental metrics highlight robust profitability and efficient capital utilisation.<\/p>\n<ul>\n<li>Significant 10.31% price rise today.<\/li>\n<li>Strong RSI indicating positive momentum.<\/li>\n<li>Impressive ROE and ROCE compared to industry peers.<\/li>\n<li>Attractive valuation metrics within the sector.<\/li>\n<\/ul>\n<p>Investors should continue to monitor the company&#8217;s performance, particularly in terms of its technical indicators and market positioning, to assess potential investment opportunities.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Ambalal_Sarabhai_Enterprises_Ltd\"><\/span><strong>About Ambalal Sarabhai Enterprises Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ambalal Sarabhai Enterprises Ltd. is a prominent player in the Pharmaceuticals &#038; Drugs industry, operating within the Healthcare sector. The company is engaged in the development, manufacturing, and marketing of pharmaceutical products, catering to a diverse range of therapeutic areas. With a focus on innovation and quality, Ambalal Sarabhai Enterprises Ltd. aims to deliver effective healthcare solutions to its customers.<\/p>\n<p>The company&#8217;s business segments include the production of active pharmaceutical ingredients (APIs) and finished dosage forms, serving both domestic and international markets. As a Micro Cap company, Ambalal Sarabhai Enterprises Ltd. is well-positioned to leverage its expertise and expand its market presence within the competitive Pharmaceuticals &#038; Drugs industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Ambalal_Sarabhai_Enterprises_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Ambalal Sarabhai Enterprises Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/ambalalsa\/ambalal-sarabhai-enterprises-ltd-share-price-today\">Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors and market enthusiasts can track the live share price of Ambalal Sarabhai Enterprises Ltd. on Univest, along with key technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, including 52-week levels and detailed analysis, to help investors make informed decisions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Ambalal_Sarabhai_Enterprises_Ltd\"><\/span><strong>What is the current share price of Ambalal Sarabhai Enterprises Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Ambalal Sarabhai Enterprises Ltd. is Rs 41.1, reflecting a 10.31% increase from the previous close of Rs 37.26. The stock moved 10.31% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Ambalal_Sarabhai_Enterprises_Ltd_share_price_rise_today\"><\/span><strong>How much did Ambalal Sarabhai Enterprises Ltd. share price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ambalal Sarabhai Enterprises Ltd. share price rose by 10.31% today, reaching a high of Rs 42 during the trading session. The stock moved 10.31% during the session. The intraday range extended from Rs 36.99 to Rs 42.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Ambalal_Sarabhai_Enterprises_Ltd\"><\/span><strong>What is the market capitalisation of Ambalal Sarabhai Enterprises Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Ambalal Sarabhai Enterprises Ltd. is Rs 267.22 crore, categorising it as a Micro Cap company. The company operates in the Healthcare sector. Its P\/E ratio is 16.04x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Ambalal_Sarabhai_Enterprises_Ltd\"><\/span><strong>What is the P\/E ratio of Ambalal Sarabhai Enterprises Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ambalal Sarabhai Enterprises Ltd. has a P\/E ratio of 16.04, which is below the industry median of 25.88, indicating a relatively attractive valuation. The company trades at a P\/E ratio of 16.04x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Ambalal_Sarabhai_Enterprises_Ltds_ROE_compare_to_industry_peers\"><\/span><strong>How does Ambalal Sarabhai Enterprises Ltd.&#39;s ROE compare to industry peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ambalal Sarabhai Enterprises Ltd.&#39;s ROE of 48.74% is significantly higher than the industry median of 10.7%, showcasing superior profitability. ROE stands at 48.74%. ROCE stands at 45.53%. The relevant peer median ROE is 10.7%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Ambalal_Sarabhai_Enterprises_Ltd_operate_in\"><\/span><strong>What sector does Ambalal Sarabhai Enterprises Ltd. operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ambalal Sarabhai Enterprises Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals &amp; Drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals &amp; Drugs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_ROCE_of_Ambalal_Sarabhai_Enterprises_Ltd\"><\/span><strong>What is the ROCE of Ambalal Sarabhai Enterprises Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ambalal Sarabhai Enterprises Ltd. has a ROCE of 45.53%, highlighting efficient capital utilisation compared to industry peers. ROE stands at 48.74%. ROCE stands at 45.53%. The relevant peer median ROE is 10.7%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Ambalal_Sarabhai_Enterprises_Ltds_PB_ratio_compare_to_the_industry\"><\/span><strong>How does Ambalal Sarabhai Enterprises Ltd.&#39;s P\/B ratio compare to the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/B ratio of Ambalal Sarabhai Enterprises Ltd. is 1.8, slightly above the industry median of 1.77, suggesting a fair valuation. The company trades at a P\/E ratio of 16.04x.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ambalal Sarabhai Enterprises Ltd. Share Price rises to Rs Rs 41.1. marking a 10.31% rise today. clearing the 8.1% threshold for Micro Cap stocks. Market cap<\/p>\n","protected":false},"author":29,"featured_media":183529,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-183532","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["183529"],"rank_math_title":["Ambalal Sarabhai Share Price Gains 10.31% in Today's Trading"],"rank_math_description":["Ambalal Sarabhai Enterprises Ltd. Share Price rises 10.31% today. Explore price action, technicals, fundamentals, and sector analysis for insights."],"rank_math_focus_keyword":["Ambalal Sarabhai Enterprises Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Ambalal_Sarabhai_Enterprises_Ltd_AMBALALSA_Share_Price_Rises_Over_10_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/183532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=183532"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/183532\/revisions"}],"predecessor-version":[{"id":183535,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/183532\/revisions\/183535"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/183529"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=183532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=183532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=183532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}